These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 26517011)
21. The effect of glycolic acid monomer ratio on the emulsifying activity of PLGA in preparation of protein-loaded SLN. Xie S; Wang S; Zhu L; Wang F; Zhou W Colloids Surf B Biointerfaces; 2009 Nov; 74(1):358-61. PubMed ID: 19717285 [TBL] [Abstract][Full Text] [Related]
23. Impact of PEG and PEG-b-PAGE modified PLGA on nanoparticle formation, protein loading and release. Rietscher R; Czaplewska JA; Majdanski TC; Gottschaldt M; Schubert US; Schneider M; Lehr CM Int J Pharm; 2016 Mar; 500(1-2):187-95. PubMed ID: 26784983 [TBL] [Abstract][Full Text] [Related]
24. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method. Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954 [TBL] [Abstract][Full Text] [Related]
25. Effect of additives on the release of a model protein from PLGA microspheres. Kang F; Singh J AAPS PharmSciTech; 2001 Dec; 2(4):30. PubMed ID: 14727867 [TBL] [Abstract][Full Text] [Related]
26. Release profile characteristics of biodegradable-polymer-coated drug particles fabricated by dual-capillary electrospray. Lee YH; Mei F; Bai MY; Zhao S; Chen DR J Control Release; 2010 Jul; 145(1):58-65. PubMed ID: 20346381 [TBL] [Abstract][Full Text] [Related]
27. A simple and general method for preparing antibody-PEG-PLGA sub-micron particles using electrospray technique: an in vitro study of targeted delivery of cisplatin to ovarian cancer cells. Bai MY; Liu SZ Colloids Surf B Biointerfaces; 2014 May; 117():346-53. PubMed ID: 24681046 [TBL] [Abstract][Full Text] [Related]
28. Enhancement of Antifungal Activity of Juglone (5-Hydroxy-1,4-naphthoquinone) Using a Poly(d,l-lactic-co-glycolic acid) (PLGA) Nanoparticle System. Arasoglu T; Mansuroglu B; Derman S; Gumus B; Kocyigit B; Acar T; Kocacaliskan I J Agric Food Chem; 2016 Sep; 64(38):7087-94. PubMed ID: 27600097 [TBL] [Abstract][Full Text] [Related]
29. A comparative assessment of continuous production techniques to generate sub-micron size PLGA particles. Operti MC; Fecher D; van Dinther EAW; Grimm S; Jaber R; Figdor CG; Tagit O Int J Pharm; 2018 Oct; 550(1-2):140-148. PubMed ID: 30144511 [TBL] [Abstract][Full Text] [Related]
30. PLGA-based microparticles loaded with bacterial-synthesized prodigiosin for anticancer drug release: Effects of particle size on drug release kinetics and cell viability. Obayemi JD; Danyuo Y; Dozie-Nwachukwu S; Odusanya OS; Anuku N; Malatesta K; Yu W; Uhrich KE; Soboyejo WO Mater Sci Eng C Mater Biol Appl; 2016 Sep; 66():51-65. PubMed ID: 27207038 [TBL] [Abstract][Full Text] [Related]
31. Effect of PLGA as a polymeric emulsifier on preparation of hydrophilic protein-loaded solid lipid nanoparticles. Xie S; Wang S; Zhao B; Han C; Wang M; Zhou W Colloids Surf B Biointerfaces; 2008 Dec; 67(2):199-204. PubMed ID: 18829272 [TBL] [Abstract][Full Text] [Related]
32. Protein encapsulated core-shell structured particles prepared by coaxial electrospraying: investigation on material and processing variables. Zamani M; Prabhakaran MP; Thian ES; Ramakrishna S Int J Pharm; 2014 Oct; 473(1-2):134-43. PubMed ID: 24998509 [TBL] [Abstract][Full Text] [Related]
33. Optimization of PLGA formulation containing protein or peptide-based antigen: Recent advances. Hajavi J; Ebrahimian M; Sankian M; Khakzad MR; Hashemi M J Biomed Mater Res A; 2018 Sep; 106(9):2540-2551. PubMed ID: 29633511 [TBL] [Abstract][Full Text] [Related]
34. Hydrophobic ion pairing of a minocycline/Ca(2+)/AOT complex for preparation of drug-loaded PLGA nanoparticles with improved sustained release. Holmkvist AD; Friberg A; Nilsson UJ; Schouenborg J Int J Pharm; 2016 Feb; 499(1-2):351-357. PubMed ID: 26773599 [TBL] [Abstract][Full Text] [Related]
35. PLGA Nanoparticles as Subconjunctival Injection for Management of Glaucoma. Salama HA; Ghorab M; Mahmoud AA; Abdel Hady M AAPS PharmSciTech; 2017 Oct; 18(7):2517-2528. PubMed ID: 28224390 [TBL] [Abstract][Full Text] [Related]
36. Prediction of dexamethasone release from PLGA microspheres prepared with polymer blends using a design of experiment approach. Gu B; Burgess DJ Int J Pharm; 2015 Nov; 495(1):393-403. PubMed ID: 26325309 [TBL] [Abstract][Full Text] [Related]
37. Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs. Dong Y; Feng SS Biomaterials; 2005 Oct; 26(30):6068-76. PubMed ID: 15894372 [TBL] [Abstract][Full Text] [Related]
38. A novel biodegradable system based on gelatin nanoparticles and poly(lactic-co-glycolic acid) microspheres for protein and peptide drug delivery. Li JK; Wang N; Wu XS J Pharm Sci; 1997 Aug; 86(8):891-5. PubMed ID: 9269865 [TBL] [Abstract][Full Text] [Related]
39. NanoCipro encapsulation in monodisperse large porous PLGA microparticles. Arnold MM; Gorman EM; Schieber LJ; Munson EJ; Berkland C J Control Release; 2007 Aug; 121(1-2):100-9. PubMed ID: 17604870 [TBL] [Abstract][Full Text] [Related]
40. Formulation and evaluation of tacrolimus-loaded galactosylated Poly(lactic-co-glycolic acid) nanoparticles for liver targeting. Mistry NP; Desai JL; Thakkar HP J Pharm Pharmacol; 2015 Oct; 67(10):1337-48. PubMed ID: 25944126 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]